Professor Tim Briggs is a Consultant Orthopaedic Surgeon at the Royal National Orthopaedic Hospital (RNOH) in Stanmore, London. His documented specialties include hip and knee replacement, rehabilitation and cartilage transplantation, as well as sarcoma. His specialist clinical interests include bone and soft-tissue sarcomas, complex hip and knee surgery, complex revision hip and knee surgery and cartilage transplantation.

Professor Briggs qualified from The Royal London Hospital in 1982 and subsequently completed senior registrar training before being appointed as a consultant at RNOH in 1992. His long-standing association with the hospital has included clinical, research, educational and leadership responsibilities.

His orthopaedic practice combines specialist cancer surgery with complex joint reconstruction. Sarcoma surgery can involve removal of bone or soft-tissue tumours followed by reconstruction designed to preserve function where clinically appropriate. Such treatment commonly requires multidisciplinary planning involving orthopaedic surgeons, oncologists, radiologists, pathologists, physiotherapists and specialist nurses.

Professor Briggs has specialist interests in complex hip and knee surgery, including revision procedures. Revision joint replacement is performed when a previous artificial joint requires further surgery, potentially because of loosening, wear, infection, instability, fracture or other complications. Complex cases can require detailed imaging, implant assessment and reconstruction planning.

Cartilage transplantation is another area listed among his clinical interests. Cartilage-restoration procedures may be considered in selected patients with cartilage damage, depending on the location and extent of the injury and the patient's individual circumstances.

His research interests include reconstruction of bone sarcomas, cartilage transplantation techniques, metal-ion studies and other orthopaedic topics. RNOH also records his involvement in research and professional organisations within orthopaedics and orthopaedic oncology.

Professor Briggs has held several senior leadership positions. RNOH records that he served as Medical Director for 15 years and later took national NHS leadership responsibilities related to clinical quality, improvement and elective recovery. He has also served as President of the British Orthopaedic Association.

For patients seeking specialist orthopaedic treatment in London, his profile is relevant to complex joint surgery, revision hip and knee replacement, cartilage transplantation and musculoskeletal tumour management.

International patients considering treatment at RNOH should provide appropriate medical documentation, including imaging, pathology reports, previous operative notes and treatment histories where available. The specialist team can then determine the appropriate assessment pathway.

Treatment for bone and soft-tissue tumours varies according to tumour type, location, stage and other clinical factors. Treatment may involve surgery, chemotherapy, radiotherapy or combinations of these approaches. Joint replacement and revision surgery likewise require individual assessment.

Professor Briggs' documented clinical and professional profile makes him relevant to patients researching complex orthopaedic surgery, sarcoma services and specialist joint reconstruction at RNOH.